On Monday (August 13) a cannabis operator in Canada with operations in the US, expanded its reach in Nevada and California thanks to its acquisition of a local producer.

Golden Leaf Holdings (CSE:GLH,OTCQB:GLDFF) is set to buy the assets of Tahoe Hydroponics Company and 11T, collectively known as Tahoe, for roughly C$52.4 million in which Tahoe shareholders will obtain Golden Leaf shares.


Golden Leaf will issue C$11.1 million in cash and approximately 202 million shares of the company representing a value of C$41.3 million to Tahoe shareholders.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“Combined with high revenue growth and cash flow generation, [Tahoe] align perfectly with our strategic vision of being a premier vertically integrated seed-to-sale cannabis provider,” William Simpson, CEO of Golden Leaf said.

The executive for the cannabis operator said the new acquisition for Golden Leaf counts with brand recognition in the Nevada market.

Ray Schiavone, CEO of Tahoe Golden Leaf brings “established expertise in extraction, product development and retail operations” as part of the acquisition. Schiavone added seeing and understanding the value proposition from Golden Leaf makes it an “incredible opportunity” for Tahoe.

Once the acquisition is completed Tahoe shareholders will own a 25.8 percent stake in the new combined venture.

According to Golden Leaf the two co-founders of Tahoe, Schiavone and Mark Bruno, will be kept in the new company for at least 18 months as part of the agreement.

New assets from acquisition for public operator

As part of the purchase, Golden Leaf will obtain control of a 21,600 square feet facility in Carson City, Nevada and a 21,600 square feet facility currently under development in Sacramento, California. The facility in California is projected to begin production in the first quarter of 2019.

Tahoe’s Nevada facility produces 4,000 pounds of cannabis product per year and, thanks to its distribution platform in the state, Golden Leaf perceives a 56 market entry across the state through adult-use dispensaries.

Investor takeaway

Following an initial excitement for the acquisition the markets soured on Golden Leaf, with the company’s share price showing a 2.17 percent dip as of 2:00 p.m. EST on Monday.

Golden Leaf’s shares hold a “Buy” rating from Canaccord Genuity analyst Matt Bottomley. The analyst slapped the company with a one year price target of C$0.50. As of this writing shares for Golden Leaf were valued at C$0.22.

Don’t forget to follow us @INN_Cannabis for real-time news updates! 

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less